TESA 10mg

TESA (Tesamorelin) is a stable, synthetic analog of Growth Hormone-Releasing Hormone (GHRH) optimized for long-term metabolic health. Its primary benefits are the targeted reduction of visceral adipose tissue (VAT)—the harmful fat stored around internal organs—as well as improvements in body composition, lipid profiles, and liver fat markers, all while preserving lean muscle mass.<br><br>Tesamorelin functions by binding to the GHRH receptor in the pituitary gland, inducing a steady, pulsatile release of endogenous growth hormone. This increase in growth hormone and subsequently IGF-1 facilitates enhanced lipolysis, specifically within visceral fat stores. Its structural modification with a trans-3-hexenoic acid group provides enhanced resistance to enzymatic degradation, allowing for sustained biological activity.<br><br>Research backing for Tesamorelin includes FDA-indicated trials demonstrating its efficacy in reducing excess abdominal fat. Clinical literature consistently supports its role in improving metabolic health markers, making it a highly regarded compound in research involving body composition, endocrinology, and the management of metabolic disturbances.